These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 532592)

  • 1. Serum calcitonin and bone mineral content in patients with osteogenesis imperfecta.
    Nielsen HE; Pedersen U; Hansen HH; Elbrønd O
    Acta Orthop Scand; 1979 Dec; 50(6 Pt 1):639-43. PubMed ID: 532592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral content in osteogenesis imperfecta tarda and in otosclerosis.
    Pedersen U; Nielsen HE; Jensen KJ; Elbrønd O; Hansen HH
    J Laryngol Otol; 1979 Jul; 93(7):697-702. PubMed ID: 469399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effects of human calcitonin in osteogenesis imperfecta.
    Pedersen U; Charles P; Hansen HH; Elbrønd O
    Acta Orthop Scand; 1985 Jun; 56(3):260-4. PubMed ID: 4036580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineral changes in a transgenic mouse model for osteogenesis imperfecta.
    Cassella JP; Pereira R; Prockop DJ; Ali SY
    Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microanalytical study of bone mineral in a transgenic mouse model for brittle bone disease.
    Cassella JP; Ali SY
    Cell Biol Int; 1993 Jul; 17(7):693-4. PubMed ID: 8374602
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma osteocalcin levels in patients with osteogenesis imperfecta.
    Castells S; Yasumura S; Fusi MA; Colbert C; Bachtell RS; Smith S
    J Pediatr; 1986 Jul; 109(1):88-91. PubMed ID: 3487629
    [No Abstract]   [Full Text] [Related]  

  • 7. Total body and regional analysis by dual-photon absorptiometry in osteogenesis imperfecta.
    Nuti R; Righi G; Turchetti V; Martini G; Lepore C
    Ann N Y Acad Sci; 1988; 543():180-5. PubMed ID: 3265046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
    Duriez J; Flautre B
    Nouv Presse Med; 1975 Jan; 04(2):97-100. PubMed ID: 1138231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
    Rosenberg E; Lang R; Boisseau V; Rojanasathit S; Avioli LV
    J Clin Endocrinol Metab; 1977 Feb; 44(2):346-55. PubMed ID: 557059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S; Lu C; Baker RK; Wallach S
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium, phosphorus, and bone metabolism in the fetus and newborn.
    Kovacs CS
    Early Hum Dev; 2015 Nov; 91(11):623-8. PubMed ID: 26363942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin and phosphate metabolism. Analysis of active calcium and phosphorus in children treated with Calcitar].
    Vulović D; Stojanov Lj; Nedeljković V; Banicević M; Zamurović D
    Srp Arh Celok Lek; 1977 Nov; 105(11):967-74. PubMed ID: 617001
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of osteogenesis imperfecta with synthetic salmon calcitonin.
    Castells S; Colbert C; Chakrabarti C; Bachtell RS; Kassner EG; Yasumura S
    J Pediatr; 1979 Nov; 95(5 Pt 1):807-11. PubMed ID: 573785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of porcine calcitonin in osteogenesis imperfecta tarda.
    Castells S; Inamdar S; Baker RK; Wallach S
    J Pediatr; 1972 May; 80(5):757-62. PubMed ID: 5062955
    [No Abstract]   [Full Text] [Related]  

  • 15. Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta.
    Dickson IR; Bagga M; Paterson CR
    Calcif Tissue Int; 1983; 35(1):16-20. PubMed ID: 6839187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin and calcium therapy in an infant with osteogenesis imperfecta congenita.
    Lanes R; Toledo T; Obregon O
    J Am Coll Nutr; 1983; 2(1):101-6. PubMed ID: 6886241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin.
    Hurley DL; Tiegs RD; Wahner HW; Heath H
    N Engl J Med; 1987 Aug; 317(9):537-41. PubMed ID: 3614305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry.
    Nakatsuka K; Nishizawa Y; Hagiwara S; Koyama H; Miki T; Ochi H; Morii H
    Calcif Tissue Int; 1990 Dec; 47(6):378-82. PubMed ID: 2292081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.
    Edouard T; Husseini A; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1243-9. PubMed ID: 22319032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency.
    McDermott MT; Kidd GS; Blue P; Ghaed V; Hofeldt FD
    J Clin Endocrinol Metab; 1983 May; 56(5):936-9. PubMed ID: 6833470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.